Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy

<b>Background:</b> Rebound hypoxemia may occur after cessation of corticosteroid therapy for COVID-19 pneumonitis. We aimed to determine the incidence of this phenomenon in mechanically ventilated patients with COVID-19 completing corticosteroid therapy. <b>Methods:</b> We conducted a retrospective observational cohort study across 2 tertiary ICUs from September to December 2021. We included all adult patients receiving invasive mechanical ventilation on completion of a 10-day course of dexamethasone for COVID pneumonitis. Our primary outcome was change in P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub> ratio in the 7 days following cessation of dexamethasone. Secondary outcomes included duration of ventilation, frequency of corticosteroid recommencement, and mortality. <b>Results:</b> We studied 88 subjects. Median age was 61 years (interquartile range [IQR] 51-67), and median duration of mechanical ventilation was 14 days (IQR 11-26). On completion of dexamethasone, 62 subjects (70%) remained off corticosteroid therapy for the subsequent 7 days. Of these, 63% (<i>n =</i> 20) had a stable P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub> ratio on day 7 (mean change 197 ± 42 mm Hg to 258 ± 83 mm Hg). Subjects who had a reduction in P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub> ratio >20 mm Hg by day 7 (mean change 214 ± 68 mm Hg to 152 ± 78 mm Hg) were more likely to die in hospital (<i>P</i> < .001). These subjects had a higher C-reactive protein level at time of steroid cessation (204 ± 87 mg/L, <i>P</i> = .17), which remained persistently elevated (206 ± 89 mg/L, <i>P</i> = .01) on day 7. The 30% of subjects who recommenced steroids required a longer duration of ventilation (13.5 vs 24.5 d, <i>P</i> = .002) but showed no differences in ICU mortality (19% vs 27%, <i>P</i> = .43). <b>Conclusions:</b> Rebound hypoxemia and steroid recommencement were common occurrences in mechanically ventilated subjects with COVID-19. Rebound hypoxemia was associated with higher mortality. Steroid recommencement was associated with longer duration of mechanical ventilation but no significant difference in mortality.

Authors

Institutions

Publication Details

Journal
Respiratory Care
Published
2025-04-03
DOI
https://doi.org/10.1089/respcare.12494
Primary Topic
Thermal Regulation in Medicine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy

Hannah Rotherham, Rahul Costa‐Pinto, Rinaldo Bellomo, Padeepa Perera et al.
Respiratory Care
Thermal Regulation in Medicine
article

Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy

Hannah Rotherham, Rahul Costa‐Pinto, Rinaldo Bellomo, Padeepa Perera, Zachary O’Brien, Vicky Chen, Bing Xu, Christopher Massarany
article en

Abstract

<b>Background:</b> Rebound hypoxemia may occur after cessation of corticosteroid therapy for COVID-19 pneumonitis. We aimed to determine the incidence of this phenomenon in mechanically ventilated patients with COVID-19 completing corticosteroid therapy. <b>Methods:</b> We conducted a retrospective observational cohort study across 2 tertiary ICUs from September to December 2021. We included all adult patients receiving invasive mechanical ventilation on completion of a 10-day course of dexamethasone for COVID pneumonitis. Our primary outcome was change in P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub> ratio in the 7 days following cessation of dexamethasone. Secondary outcomes included duration of ventilation, frequency of corticosteroid recommencement, and mortality. <b>Results:</b> We studied 88 subjects. Median age was 61 years (interquartile range [IQR] 51-67), and median duration of mechanical ventilation was 14 days (IQR 11-26). On completion of dexamethasone, 62 subjects (70%) remained off corticosteroid therapy for the subsequent 7 days. Of these, 63% (<i>n =</i> 20) had a stable P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub> ratio on day 7 (mean change 197 ± 42 mm Hg to 258 ± 83 mm Hg). Subjects who had a reduction in P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub> ratio >20 mm Hg by day 7 (mean change 214 ± 68 mm Hg to 152 ± 78 mm Hg) were more likely to die in hospital (<i>P</i> < .001). These subjects had a higher C-reactive protein level at time of steroid cessation (204 ± 87 mg/L, <i>P</i> = .17), which remained persistently elevated (206 ± 89 mg/L, <i>P</i> = .01) on day 7. The 30% of subjects who recommenced steroids required a longer duration of ventilation (13.5 vs 24.5 d, <i>P</i> = .002) but showed no differences in ICU mortality (19% vs 27%, <i>P</i> = .43). <b>Conclusions:</b> Rebound hypoxemia and steroid recommencement were common occurrences in mechanically ventilated subjects with COVID-19. Rebound hypoxemia was associated with higher mortality. Steroid recommencement was associated with longer duration of mechanical ventilation but no significant difference in mortality.

Respiratory CareVol. 70(8)
The Royal Melbourne Hospital (AU), The University of Melbourne (AU), Austin Hospital (AU), Australian and New Zealand Intensive Care Society (AU), Royal Dental Hospital of Melbourne (AU)
Openalex Percentile: Top 92%
Thermal Regulation in Medicine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.